This inventor holds 23 USPTO granted patents and 1 EPO patent, primarily in Chemical Compounds. Top assignees: Smithkline Beecham Corporation, Aventis Pharmaceuticals Inc., Glaxosmithkline Intellectual Property (No.2) Limited. Active years: 1997-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Pottstown, PA (US) (1997 - 1999)
- Douglassville, PA (US) (1999 - 2009)
- Collegeville, PA (US) (2005 - 2011)
- Stowe, PA (US) (2014)
Company Filing History:
20 out of 2,198 
1 out of 207 
1 out of 95 
Years Active: 1997-2014
Areas of Expertise:
Title: Joseph M. Karpinski: Innovator in Peptide Deformylase Inhibitors
Introduction
Joseph M. Karpinski is a prominent inventor based in Pottstown, PA, recognized for his contributions to pharmaceutical innovations. With an impressive portfolio of 23 patents, he has played a crucial role in advancing treatments aimed at combating bacterial infections.
Latest Patents
Among his notable inventions, Karpinski has developed peptide deformylase inhibitors. His latest patents include a novel compound of Formula (I) and its pharmaceutically acceptable salts, accompanied by innovative pharmaceutical compositions and methods for treatment. These inventions specifically target bacterial infections and inhibit the activity of bacterial peptide deformylase (PDF). Additionally, his work on other PDF inhibitors introduces new methods for their effective use in medical applications.
Career Highlights
Karpinski has a distinguished career and has worked with leading companies in the pharmaceutical industry, including SmithKline Beecham Corporation and Aventis Pharmaceuticals Inc. His experiences in these organizations have enriched his expertise, driving forward his research and development efforts in the biomedical field.
Collaborations
Throughout his career, Joseph has collaborated with notable colleagues such as Siegfried B. Christensen, IV and M. Dominic Ryan. These partnerships have fostered innovation and enhanced the development of his patented technologies.
Conclusion
In summary, Joseph M. Karpinski is a significant figure in the field of pharmaceutical inventions, particularly in the area of peptide deformylase inhibitors. His 23 patents reflect his dedication to advancing healthcare solutions and his influence on the industry through his work at prominent pharmaceutical companies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile